Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11b(high)/Gr1(high) myeloid cells

The anti-VEGF humanized antibody bevacizumab suppresses various malignancies, but tumors can acquire drug resistance. Preclinical studies suggest myeloid-derived suppressor cells (MDSCs) may be associated with tumor refractoriness to anti-VEGF treatment. Here we report a novel mechanism of tumor esc...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwai, Toshiki, Harada, Yui, Saeki, Hiroshi, Oki, Eiji, Maehara, Yoshihiko, Yonemitsu, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915143/
https://www.ncbi.nlm.nih.gov/pubmed/29707135
http://dx.doi.org/10.18632/oncotarget.24811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915143/
https://www.ncbi.nlm.nih.gov/pubmed/29707135
http://dx.doi.org/10.18632/oncotarget.24811

Ejemplares similares